Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic
  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Imvax to Present New Data on Tumor-Derived Immunotherapy Platform at 2022 SITC Meeting

Imvax, Inc., a clinical-stage biotechnology company developing personalized, whole tumor-derived immunotherapies, today announced two poster presentations at the 2022 Society for Immunotherapy of Cancer (SITC) Meeting in Boston, MA, from November 10-12, 2022.

At the meeting, Imvax will present data providing new insights into the mechanism of action of the company’s most advanced product candidate, IGV-001, for the treatment of glioblastoma. The company also will share in vivo data supporting the antitumor activity of Imvax’s tumor-derived immunotherapy platform for ovarian, liver and bladder cancers.

The details of the poster presentations are below:

Title: “Autologous tumor cell immunotherapeutic platform induces stress-correlated immunogenic cell death leading to immune activation within the draining lymph nodes”

Number: 1071

Timing: November 10, 2022, 9:00 am – 9:00 pm EST

Presenter: Christopher Cultrara, Ph.D.

Title: “Personalized immunotherapeutic platform, with evidence of clinical activity in glioblastoma, protects mice against ovarian, liver & bladder cancer tumor challenges”

Number: 1398

Timing: November 11, 2022, 9:00 am – 8:30 pm EST

Presenter: Amelia Zellander, Ph.D.

About Imvax, Inc.

Imvax is a clinical-stage biotechnology company with a unique platform technology focused on delivering personalized, whole tumor-derived immunotherapies across a range of solid tumors. Imvax’s portfolio includes several programs designed to stimulate a patient’s immune system against the full antigen signature of their tumor. Imvax’s most advanced program is IGV-001 for the treatment of glioblastoma. Imvax is headquartered in Philadelphia, PA. For additional information, please visit www.imvax.com.

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.